INVESTIGATIVE INTELLIGENCE BRIEF

SUBJECT: Representative Katherine M. Clark (MA-05)
CURRENT ROLE: Democratic Whip / Minority Whip, U.S. House of Representatives
DATE OF BRIEF: October 2, 2026
ANALYST NOTE: Evaluated strictly from compiled primary disclosures, congressional voting records, campaign filings, and labelled analytic inferences.

1. CONFIRMED PRIMARY-SOURCE FACTS

A. Official Profile, Leadership, & Committees

• Current Office & Tenure: U.S. Representative for Massachusetts's 5th Congressional District; serving continuously since winning a December 2013 special election [Government / Congressional Records].
• Leadership Roles: Elected House Minority Whip in November 2022 (second-highest-ranking House Democrat and highest-ranking woman in House Democratic leadership). Previously served as Assistant Speaker (2021–2023) and Vice Chair of the House Democratic Caucus (2019–2021) [Government / Congressional Records].
• Committee Assignments: House Committee on Appropriations. Holds seats on three subcommittees:
  1. Labor, Health and Human Services, Education, and Related Agencies
  2. Transportation, Housing and Urban Development, and Related Agencies
  3. Legislative Branch [Government / Congressional Records].
• Caucus Affiliations: Member of the Medicare for All Caucus and Congressional Progressive Caucus [Government / Congressional Records].

B. Personal Wealth & Financial Disclosures

• Net Worth: Estimated at $12.4 million to $14.8 million as of 2025 (ranks 73rd–88th in Congress per Quiver Quantitative). Entering net worth was approximately $6.8 million in 2013, roughly doubling across her congressional tenure [Financial Disclosures / Government Data].
• Stock & Options Transactions:
  • New York Community Bancorp (NYCB): Sold stock valued at $1,001–$15,000 from two trusts on March 1, 2024 (reported April 2, 2024) following a roughly 70% plunge in NYCB shares earlier that year [Periodic Transaction Reports / Congressional Disclosures].
  • Procter & Gamble (P&G): Sold shares valued at $30,002–$100,000 in 2025 [Periodic Transaction Reports / Congressional Disclosures].
  • Hormel Foods: Actively traded stock options in 2025 [Periodic Transaction Reports / Congressional Disclosures].

C. Campaign Finance Overview (Career: 2013–2024)

• Total Receipts: $13,586,345 raised across her House career [FEC Disclosures].
• Total Disbursements: $12,260,454 spent across her House career [FEC Disclosures].
• Cash on Hand: $1,325,890 as of December 31, 2024 [FEC Disclosures].
• Top Contributing Industry Sectors:
  1. Securities & Investment: $1,039,039
  2. Pharmaceuticals / Health Products: $822,926
  3. Real Estate: $769,690
  4. Lawyers / Law Firms: $711,351
  5. Lobbyists: $603,234 [FEC Disclosures].
• Top Organizational Donors & Issue Lobbies:
  • AIPAC (American Israel Public Affairs Committee): $416,380 (career top donor organization) [FEC Disclosures].
  • JStreetPAC: $111,866 [FEC Disclosures].
  • Total Pro-Israel Group Contributions: Exceeds $700,000, representing her single largest issue-funding network [FEC Disclosures].

D. Congressional Voting Record & Public Statements

E. Massachusetts 5th Congressional District Baseline

• Geography & Partisanship: Northern/western Boston suburbs (Cambridge, Medford, Malden, Melrose, Revere, Winthrop, Framingham/MetroWest); safe Democratic seat (D+100 index), population ~778,640 [Census / Election Data].
• Demographics: Median household income: $130,807; Poverty rate: 4.8%; Bachelor’s degree or higher: 61.4% (vs. 33.7% national); Homeownership rate: 58.3%; Median rent: $2,262; Racial demographics: 64.5% White, 13.7% Asian, 11.3% Hispanic [Census ACS Data].
• Dominant Industries by Share: NAICS 6221 (Hospitals, 15.5%); NAICS 6113 (Colleges/Universities, 14.5%); NAICS 5417 (Scientific R&D, 11.0%); NAICS 5415 (Computer Systems Design, 8.2%); NAICS 5241 (Insurance Carriers, 6.5%) [Economic Census / BLS Data].
• Anchor Employers: Mass General Brigham (80,000 employees); Harvard University (19,000); MIT (13,000); Biogen Inc. (7,500); Tufts University (5,000) [State / District Economic Profiles].
• District Ballot Measures:
  • 2020 Question 1 (Right to Repair / Vehicle Data Access): Passed statewide (74.9% Yes to 25.1% No).
  • 2022 Question 4 (Driver's License Access for Undocumented Immigrants): Upheld statewide (53.6% Yes to 46.4% No) [Massachusetts Secretary of the Commonwealth].

2. KEY FINANCIAL & POLITICAL FLOWS

                  ┌──────────────────────────────────────────────────┐
                  │            KATHERINE CLARK CAMPAIGN              │
                  │   Career Raised: $13.58M | Cash on Hand: $1.33M  │
                  └─────────────────────────┬────────────────────────┘
                                            │
        ┌───────────────────────────────────┼───────────────────────────────────┐
        ▼                                   ▼                                   ▼
┌──────────────────────┐        ┌──────────────────────┐        ┌──────────────────────┐
│  FINANCIAL SECTOR    │        │  HEALTH & PHARMA     │        │  PRO-ISRAEL GROUPS   │
│  $1,039,039 (Top)    │        │  $822,926 (Rank 2)   │        │  >$700,000 Total     │
└──────────┬───────────┘        └──────────┬───────────┘        └──────────┬───────────┘
           │                               │                               │
   • BlackRock ($10k)              • Fresenius ($10k)              • AIPAC ($416,380)
   • Fidelity ($10k)               • Boston Scientific ($10k)      • JStreetPAC ($111,866)
   • BNY Mellon ($10k)             • Takeda ($10k)
   • Carlyle Group ($10k)          • Cencora ($7.5k)
   • SIFMA PAC ($5k)               • Vertex ($5k) / Amgen ($5k)

1. Corporate & Sector PAC Flows (2024–2026 Cycles)

• Financial Services & Asset Management: Maximum or near-maximum multi-cycle PAC contributions from BlackRock ($10,000, 2024), FMR LLC / Fidelity ($10,000, 2024), BNY Mellon ($10,000, 2026), Carlyle Group ($10,000, 2024), Capital Group ($10,000, 2024), LPL Financial ($10,000, 2024), Wells Fargo ($10,000, 2024), Bank of America ($10,000, 2024), Edward Jones ($10,000, 2026), and SIFMA ($5,000, 2024).
• Healthcare & Life Sciences: Sourced heavily from companies operating within or near MA-05's life science corridor: Fresenius Medical Care ($10,000, 2024), Boston Scientific ($10,000, 2024), Takeda Pharmaceuticals ($10,000, 2024), UnitedHealth Group ($10,000, 2024), Humana ($10,000, 2024), CVS Health ($10,000, 2024), Thermo Fisher Scientific ($10,000, 2024), Edwards Lifesciences ($8,000, 2026), Vertex Pharmaceuticals ($5,000, 2024), and Alnylam Pharmaceuticals ($5,000, 2024).
• Technology & Telecommunications: Google NetPAC ($10,000, 2024), Charter Communications ($10,000, 2024), Comcast/NBCUniversal ($10,000, 2024), Dell Technologies ($10,000, 2024), Hewlett Packard Enterprise ($10,000, 2024), Microsoft ($8,500, 2024), Amazon ($7,500, 2024), Oracle ($7,500, 2024), and Cisco Systems ($5,000, 2024).
• Defense & Aerospace: Huntington Ingalls ($10,000, 2024), Lockheed Martin ($8,000, 2024), Leidos ($6,000, 2024), and BAE Systems ($5,000, 2024).

2. Personal Wealth Liquidity

Clark's net worth roughly doubled between 2013 and 2025, reaching between $12.4M and $14.8M. Active liquidations and derivative positioning recorded in 2024–2025 include:

• Divestment from New York Community Bancorp ($1,001–$15,000) on March 1, 2024, following major banking stress disclosures.
• Disposition of $30,002–$100,000 in Procter & Gamble equities in 2025.
• Speculative derivative positioning via active Hormel Foods stock option trading in 2025.

3. NETWORK CONNECTIONS

Clark operates as a central institutional nexus in the House Democratic Caucus, balancing four distinct relationship hubs:

                  ┌──────────────────────────────────────────────┐
                  │         REP. KATHERINE CLARK (MA-05)         │
                  │   Democratic Whip | Appropriations Member    │
                  └──────┬──────────────┬──────────────┬─────────┘
                         │              │              │
         ┌───────────────┘              │              └───────────────┐
         ▼                              ▼                              ▼
┌──────────────────┐          ┌──────────────────┐          ┌──────────────────┐
│ HOUSE LEADERSHIP │          │ CONSTITUENCY &   │          │ DONOR & LOBBY    │
│ & CAUCUSES       │          │ INSTITUTIONS     │          │ ECOSYSTEM        │
├──────────────────┤          ├──────────────────┤          ├──────────────────┤
│• Minority Whip   │          │• Harvard / MIT   │          │• AIPAC ($416k)   │
│• Approp. Comm.   │          │• Tufts / MGB     │          │• Securities PACs │
│• Prog. Caucus    │          │• Biogen          │          │• Pharma PACs     │
│• M4A Caucus      │          │• 61.4% Higher Ed │          │• Big Tech PACs   │
└──────────────────┘          └──────────────────┘          └──────────────────┘

1. Democratic Leadership Hub (Party Management):

   • Structural Position: As Minority Whip, Clark is responsible for floor discipline and caucus unity.
   • Stress Points: Significant fractures emerged on immigration (48 Democratic defections on H.R. 29, the Laken Riley Act) and digital assets (71 Democratic defections on H.R. 4763, FIT21).

2. Foreign Policy & Pro-Israel Lobby Network:

   • Anchors: Strong, direct financial ties to AIPAC ($416,380 career) and JStreetPAC ($111,866 career), with cumulative pro-Israel donations surpassing $700,000.
   • Direct Traceability: Immediate walk-back within 96 hours of her August 14, 2025 remarks describing the situation in Gaza as "starvation and genocide," issuing a formal clarification to Jewish News Syndicate and Politico explicitly denying she was accusing Israel of genocide.

3. Appropriations & Regional Corporate Ecosystem:

   • Subcommittee Leverage: Her seats on Labor-HHS-Education and Transportation-HUD correspond to the top economic drivers in MA-05: academic medical centers (Mass General Brigham), research universities (Harvard, MIT, Tufts), and biotechnology (Biogen).
   • PAC Overlap: High concentration of pharmaceutical and life-sciences PAC contributions (Vertex, Alnylam, Takeda, Fresenius) mirroring the primary private-sector employers in her district.

4. INFERENTIAL CLAIMS (Clearly Labelled)

• [INFERENCE 1: Foreign Policy Messaging Cross-Pressure]
  Claim: Clark’s immediate public retraction of her August 14, 2025 statement—wherein she used the term "genocide" regarding Gaza—was directly motivated by pressure from her core donor network, specifically pro-Israel political action committees.
  Evidence Base: Pro-Israel committees constitute Clark's single largest career funding source (over $700,000, including $416,380 from AIPAC). Her initial remark occurred at an activist-aligned constituent event (Friends Committee on National Legislation) in Cambridge; her walk-back was issued to targeted media outlets (Jewish News Syndicate and Politico) within 4 to 5 days.
  Confidence Level: High.

• [INFERENCE 2: Leadership Whip Strain vs. Primary District Consensus]
  Claim: Clark prioritizes safe-seat progressive district alignment over national caucus uniformity on high-salience social and tech votes, leading to visible breaks with moderate House Democrats.
  Evidence Base: On H.R. 29 (Laken Riley Act), Clark held the line with base progressive values in MA-05 (which rejected driver's license bans for undocumented immigrants by 53.6% in 2022) even as 48 Democrats broke away. On H.R. 7521 (TikTok ban), she voted Nay against 155 Democrats, aligning with the district's highly educated, tech-dependent demographic (61.4% bachelor's degree).
  Confidence Level: Medium-High.

• [INFERENCE 3: Institutional Cross-Pressure on Budget Reconciliation (H.R. 1)]
  Claim: Clark’s vehement messaging against the 2025 budget reconciliation bill ("Big, Ugly Bill") reflected caucus leadership obligations over the narrow financial interests of her top donors and affluent constituents.
  Evidence Base: MA-05 has a median household income of $130,807 and a poverty rate of just 4.8%, meaning cuts to Medicaid/SNAP had low local impact compared to the benefits of permanent corporate tax cuts favored by her top donor sectors (Securities & Investment: $1.04M; Pharma: $822K). Her strict party-line opposition reflected leadership messaging rather than local constituent or donor economic self-interest.
  Confidence Level: Medium.

• [INFERENCE 4: Evaluation of Potential Absence-of-Evidence Claims]
  Application of Absence-of-Evidence Rules: The database notes that neither AIPAC nor JStreetPAC had registered public positions or lobbying filings on H.R. 4763 (FIT21).
  (a) Baseline rate: Issue-specific foreign policy PACs rarely lobby on domestic financial market structure bills (baseline ~0 filings).
  (b) Deviation: Absence of filings does not deviate from expected baselines.
  (c) Mundane explanation: Pro-Israel PACs focus on foreign assistance, defense authorizations, and anti-BDS legislation; crypto regulation falls outside their stated organizational charter.
  Deduction: No inference asserting that pro-Israel donors covertly influenced or took an anomalous absence of stance on crypto policy can be supported.

5. GAPS & CONTRADICTIONS

1. Major Direct Contradiction: Roll Call Vote on H.R. 4763 (FIT21)

The research database contains two mutually exclusive statements regarding Clark’s floor action on May 22, 2024:

• Fact 32 & Inferential Fact 1: Assert that Clark voted "Yea" (unverified) as one of 71 House Democrats backing the crypto market structure bill, joining Nancy Pelosi in alignment with Securities & Investment donors ($1.04M career).
• Fact 37 & Inferential Fact 6: Assert that Clark voted "Nay" on May 22, 2024, and that her official role as Minority Whip was to organize the 133-member Democratic "Nay" bloc against the bill.

Resolution Status: Unresolved in database. Requires pulling the official House Clerk Roll Call vote record (Roll No. 226, 118th Congress, 2nd Session) to confirm the official recorded vote.

2. Personal Trading Specifics & Scope Limitations

• Transaction Mechanics: Reports show Clark traded Hormel Foods options and sold $30,002–$100,000 of P&G shares in 2025, but the underlying strike prices, expiration dates, call/put classifications, and transaction gains/losses are not detailed in the database.
• Search Scope Limitations: Non-appearance of corporate campaign donations directly from academic employers (Harvard, MIT, Tufts) is a known search scope/legal reality (501(c)(3) universities are legally prohibited from operating federal PACs or making campaign contributions under 26 U.S.C. § 501(c)(3)), rather than an absence of institutional alignment.

6. RECOMMENDED RESEARCH DIRECTIONS

1. Verify Official Roll Call on H.R. 4763 (FIT21):

   • Target Document: Office of the Clerk, U.S. House of Representatives, Roll Call Vote #226 (May 22, 2024).
   • Purpose: Clarify whether Clark voted "Yea" with the 71 Democratic defectors or "Nay" with the 133-member party core.

2. Subpoena/Extract Periodic Transaction Reports (PTRs) for 2024–2025:

   • Target Source: U.S. House Office of the Clerk Financial Disclosure Portal.
   • Purpose: Obtain granular details on the Hormel Foods options positions (puts vs. calls, purchase dates, leverage) and establish whether options activity coincided with legislative actions before the House Appropriations Committee.

3. Cross-Tabulate Campaign Committee Schedule A Filings (2024–2026 Cycles):

   • Target Source: Federal Election Commission (FEC) Form 3X filings for Katherine Clark for Congress (Committee ID: C00548172).
   • Purpose: Track PAC contributions surrounding the August 14–19, 2025 Gaza remarks to determine if any major pro-Israel PAC disbursements were scheduled, delayed, or redirected immediately following her Cambridge speech and subsequent retraction.